Associate Professor Andrew Burke is a dual infectious disease and respiratory medicine specialist at The Prince Charles Hospital in Brisbane where he is director of infectious disease. His research interests include pharmacokinetics and drug dosing of mycobacterial drugs in tuberculosis and non-tuberculous mycobacterial infection, and he is affiliated with the University of Queensland Frazer Institute. Andrew has worked in TB programs in overseas settings and Australia and is on the World Health Organisation Technical Advisory Group for TB Drug Dosing. 

Dr Jack Callum is a Respiratory Medicine consultant and TB subspecialist at Homerton University Hospital, London, with a Diploma in Tropical Medicine and Public Health and TB experience across Australia, the UK, Timor-Leste, Vanuatu and Vietnam. His research spans TB genomics and drug resistance; has written textbook chapters including 'TB in Older Persons' for Oxford Geriatric Medicine, he currently advises the FLIRT and ACT5 TB trials, sits on the BTS MDR-TB Clinical Advice Service panel, and has hosted the ACTnet TB podcast since 2022.

Dr Catherine Berry is an Infectious Diseases consultant with the Hunter New England Local Health District and a conjoint lecturer at the University of Newcastle. She has extensive experience treating patients with multi-drug resistant (MDR) TB and has served as the Global Principal Investigator for the TB-PRACTECAL trial. Additionally, Dr. Berry supports the endTB initiative and has been working with MSF for over ten years on various MDR-TB clinical trials. She also has a growing interest in non-tuberculous mycobacteria (NTM).

Professor Greg Fox is Director of the Sydney Southeast Asia Centre, Professor of Respiratory Medicine at the University of Sydney, and a respiratory physician at Royal Prince Alfred Hospital. His research focuses on improving the detection, treatment, and prevention of tuberculosis (TB), particularly in high-burden settings across Southeast Asia. He directs the NHMRC Centre of Research Excellence in Tuberculosis, co-directs the University of Sydney WHO Collaborating Centre for Tuberculosis, and is an NHMRC Leadership Fellow.

Dr Gail Cross is an infectious disease physician who has worked around Australia, PNG and Singapore. She is completing her PhD through the Kirby Institute, UNSW based on the recently completed adjunctive rosuvastatin for tuberculosis treatment trial. She is interested in host-directed therapy, biomarker discovery in tuberculosis and health equity.  She currently resides in  Melbourne, Victoria, Australia with her family. 

​Dr Simone Barry is a respiratory physician at Royal Adelaide Hospital. She is the Head of the SA Tuberculosis Service and, commensurate with that position, serves as the state representative for the National TB Advisory Committee, which provides expert advice to the Australian Government on the prevention and control of TB. She holds a Master's degree in Public Health and Tropical Medicine and her Ph.D. doctoral thesis examined microRNA as a biomarker for TB.  

Dr Alice Sawka is a respiratory physician at the Royal Adelaide Hospital. In 2021 she completed a clinical fellowship in mycobacterial disease at the Princess Alexandra Hospital in Brisbane. As a tuberculosis consultant with South Australian Tuberculosis Services, she is currently part of a team working to address the evolving TB outbreak in the APY lands and within other vulnerable populations in South Australia.  She holds a Master of Public Health from Monash University.

Chris Lowbridge is a nurse and infectious diseases epidemiologist at the Menzies School of Health Research, where he co-leads the Global and Tropical Health Division and leads the TB program. His research focuses on improving TB care and prevention through epidemiology and implementation science, with projects in Indonesia, Timor-Leste, and Aboriginal communities in northern Australia. He also serves as the Regional Engagement Specialist on Australia’s National TB Advisory Committee.

Dr Victoria Grey is an infectious diseases physician at Logan Hospital and the Metro South Clinical Tuberculosis Service. She completed a mycobacterial fellowship in 2023 at the Princess Alexandra Hospital. She holds a Master of Public Health from Griffith University. Her research interests include central nervous system tuberculosis and therapeutic drug monitoring in mycobacterial disease. She is passionate about health equity including improving healthcare access to vulnerable populations. She currently resides in Brisbane.